Aronoff SL, Berkowitz K, Shreiner B, Want L
Retatrutide works as a powerful triple-agonist, meaning it works on on three key hormone receptors: The human glucagon receptor (GCGR) The glucose-dependent polypeptide receptor (GIP receptor) The glucagon-like peptide-1 receptor (GLP-1) This unique receptor profile allows retatrutide to effectively: Regulate appetite, feelings of fullness, and gastric emptying Regulate metabolism Regulate blood sugar levels The activation of the GIP, GLP-1, and GCG receptors simultaneously by retatrutide leads to better weight loss and cardiometabolic benefits compared to targeting a single receptor
In children, an x-ray can reveal internal damage resulting from childhood scurvy
Patients with preserved kidney function and tolerability to GLP-1 agents showed the most consistent responses
What information would you find most helpful in deciding whether they're right for you
The prescribing decision should always be made collaboratively between you and your healthcare team, taking into account your specific clinical circumstances, NICE guidance, and local NHS service availability